Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669K Sell
1,847
-1,009
-35% -$345K 0.08% 131
2026
Q1
$1M Buy
2,856
+86
+3% +$30.7K 0.14% 112
2025
Q4
$907K Buy
2,770
+571
+26% +$181K 0.17% 91
2025
Q3
$621K Sell
2,199
-14
-0.6% -$4.06K 0.12% 103
2025
Q2
$618K Buy
2,213
+531
+32% +$150K 0.13% 97
2025
Q1
$524K Buy
+1,682
New +$497K 0.13% 99

Other funds holding AMGN

AA Financial Advisors's AMGN Position: Q2 2026 in Review

AA Financial Advisors reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $345K and leaving 1,847 shares worth $669K. The position accounts for 0.08% of the portfolio, ranked #131.

AA Financial Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $1M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • AA Financial Advisors held 1,847 shares of Amgen worth $669K as of Q2 2026.
  • AA Financial Advisors sold 1,009 Amgen shares in Q2 2026, an estimated $345K.
  • Amgen made up 0.08% of AA Financial Advisors's portfolio in Q2 2026, its #131 holding.
  • AA Financial Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • AA Financial Advisors's Amgen position peaked at $1M in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AA Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.